Bullish & Foolish
Full LNAI fundamentals All 466 on the Survival Watch

LNAILunai Bioworks Inc.

Is Lunai Bioworks struggling financially?

Yes, by its own account. Lunai Bioworks told the SEC on 15 May 2026, in Form 10-Q, that there is substantial doubt about its ability to continue as a going concern.

Going concern disclosed May 2026

15/100

Critical

Sector
Biotech/Pharma
Market cap
$9.8M
Source filing
10-Q 15 May 2026
Balance sheet
31 Mar 2026

Cash runway

  • 3months

    If the burn speeds up

    Empty by Jul 2026

  • 5months

    If it eases off

    Empty by Aug 2026

Both rows are the same reported burn flexed 15% either way, and neither assumes the company raises a cent.

Out of cashTwo years or more

The runway math

Cash and short-term investments

$3.2M

÷

Cash burned over the last 12 months

$9.0M

What Lunai Bioworks told the SEC

…had cash and cash equivalents of $ 3,155,272 , an accumulated deficit of $ 512,014,347 and a working capital deficit of $ 15,550,002 . These conditions raise substantial doubt about the Company’s ability to continue as a going concern for one year after the date the financial statements are issued. The consolidated financial statements do not include any adjustments relating to the recoverability and classification…

Lunai Bioworks Inc., Form 10-Q, filed 15 May 2026.

Read the filing on SEC.gov

What this means

  • Not a bankruptcy filing, and not a prediction.
  • It is the company’s own statement, agreed with its auditor, that the doubt is material enough to disclose.
  • The runway is arithmetic on two reported numbers, not a forecast. Companies carry this language for years, raise money and keep going.

What else the numbers show

  • Cash burn is narrowing It is spending 40% less cash per year than it was, so the runway above is lengthening rather than shortening.

Other Biotech/Pharma companies that filed the doubt